Portfolio company
BioMoti
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops targeted drug delivery technology for cancer therapeutics, primarily serving the pharmaceutical and biotechnology industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Exomnis Biotech
This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.
Rezo Therapeutics
This biotechnology company develops drug discovery platforms and targeted therapies for oncology and other serious diseases, serving the pharmaceutical and healthcare industries.
Momentous Therapeutics
This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.
Confluence Life Sciences
This biopharmaceutical company develops kinase inhibitors to treat inflammatory disorders and cancer for pharmaceutical and biotechnology industries.
Argonaute RNA
This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.
RS Research
This biotechnology company develops targeted nanomedicine delivery platforms and polymer-drug conjugates for oncology patients and pharmaceutical researchers.
Catalyst Oncology
The company provides clinical research services for oncology trials to biotechnology and pharmaceutical firms developing cancer treatments.
Kiyatec
This company develops 3D cell culture platforms to predict patient-specific responses to cancer therapies for oncologists and biopharmaceutical companies.
